Hitting your goal weight on GLP-1s was the easy part — keeping it off is the real challenge. Learn strategies that make weight maintenance realistic, from smart medication moves to lifestyle guardrails that actually work. Don’t let biology and cravings push you back.
ADHD and obesity are more connected than most people realize. Trouble with focus, impulsivity, and dopamine regulation can make managing weight feel impossible — and excess weight can make ADHD symptoms even worse. Understanding this hidden link could change the way you approach health.
What if low testosterone isn’t about age, but a sluggish metabolism? This explores new research on Zepbound and how it may restore testosterone naturally—fixing the system instead of patching the symptom.
Zepbound does more than curb appetite—it changes how the brain responds to food. Learn the science behind food noise, why it quiets down, and what that means for cravings, control, and lasting results.
Still feeling exhausted, foggy, or inflamed—even after losing weight? GLP-1 meds like Ozempic and Wegovy might be doing more than curbing hunger. Discover what could really be draining your energy and flaring your skin.
Even after significant weight loss, many people still feel uncomfortable in their bodies. We’re exploring body dysmorphia—why it happens, how it shows up (even with GLP-1 medications), and what you can do to start healing.
MariTide is a once-monthly GLP-1 that does more than curb appetite—it blocks GIP, a hormone linked to fat storage and insulin resistance. In a Phase 2 trial with 592 adults, it led to up to 20% weight loss, lower A1C, and better fat reduction—especially with slow dose escalation.
Learn what sets MariTide apart, who it might work for, and how it compares to meds like Wegovy and Zepbound.
Orforglipron is a once-daily oral GLP-1 medication showing powerful results for people with type 2 diabetes. It lowers A1C and supports significant weight loss—all without injections, food restrictions, or lifestyle coaching. Based on the ACHIEVE-1 trial, this treatment could change how early type 2 diabetes is managed.
If walking causes burning or cramping in your legs, it could be more than just aging or being out of shape—it might be Peripheral Artery Disease (PAD). Learn how semaglutide, commonly known for weight loss and diabetes, is now showing promise in improving mobility and reducing leg pain by improving blood flow.
CagriSema and Tirzepatide are two of the most talked-about names in obesity treatment—now see how they compare. Explore the latest clinical results, real-world impacts, and what sets each medication apart when it comes to weight loss and metabolic health.
Calculate your daily calorie and protein targets to help you achieve your weight goals.
Calculate your daily calorie and protein targets to help you achieve your weight goals.
